Spain – Pharmaceutical products – Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)
awardedHospital Infantil Universitario Niño Jesús · Q2877003J
Value
€115k
Published
30 Oct 2026
Deadline
—
Type
award
33600000 · Medical equipment, pharmaceuticals & personal careES300
Description
Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)
Key facts
- Procedure
- neg-wo-call
- Regime
- publicSector
- Contract references
- A/SUM-017062/2026C01
- Category
- supplies
Awarded suppliers
- AMGEN, S.A. · A59363655 · ES511, ES
Supplier location as published: Barcelona , ES511, 08003, ES
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
technical
Procedimiento negociado por exclusividad
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 755656-2026
- First seen
- 30 Oct 2026
- Last updated
- 30 Oct 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/706a7ae3-d538-4aa1-95f4-89c8bab7245bThe source notice is authoritative — verify deadlines and documents there before bidding.